Antidiabetic copper(II)-picolinate: Impact of the first transition metal in the metallopicolinate complexes

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 14, 2007, Pages 4917-4922

  Yasumatsu, Naoko ^a   Yoshikawa, Yutaka ^a   Adachi, Yusuke ^a   Sakurai, Hiromu ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Copper(II) picolinate complex; Hypoglycemic effect; Insulinomimetic activity; Type 1 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; CHROMIUM PICOLINATE COMPLEX; COBALT PICOLINATE COMPLEX; COPPER; COPPER PICOLINATE COMPLEX; FATTY ACID; IRON PICOLINATE COMPLEX; MANGANESE; MANGANESE PICOLINATE COMPLEX; NICKEL PICOLINATE COMPLEX; OXOVANADIUM PICOLINATE COMPLEX; PICOLINIC ACID DERIVATIVE; STREPTOZOCIN; TRANSITION ELEMENT; UNCLASSIFIED DRUG; ZINC PICOLINATE COMPLEX;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; RAT; RAT STRAIN; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; CELL SURVIVAL; CHEMISTRY, PHYSICAL; COPPER; DIABETES MELLITUS, EXPERIMENTAL; FATTY ACIDS, NONESTERIFIED; HYPOGLYCEMIA; INHIBITORY CONCENTRATION 50; MALE; PICOLINIC ACIDS; RATS;

MUS; RATTUS;

EID: 34249728800     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2007.04.062     Document Type: Article

References (47)

1. Wild S., Roglic G., Sicree R., Green A., and King H. Global Burden of Disease (2003), WHO, Geneva
2. WHO study group, Diabetes mellitus (Technical report series 727); WHO: Geneva, 1985.
3. Marshall S.M. Clin. Med. 4 (2004) 277
4. Ritz E., and Haxsen V. Eur. J. Clin. Invest. 35 (2005) 66
5. Moore P.A., Weyant R.J., Mongelluzzo M.B., Myers D.E., Rossie K., Guggenheimer J., Block H.M., Huber H., and Orchard T. J. Periodontol. 70 (1999) 409
6. Shechter Y., and Karlish S.J.D. Nature 284 (1980) 556
7. Sakurai H., Kojima Y., Yoshikawa Y., Kawabe K., and Yasui H. Coord. Chem. Rev. 226 (2002) 187
8. Coulston L., and Dandona P. Diabetes 29 (1980) 665
9. Fonteles M.C., Almedia M.Q., and Larner J. Horm. Metab. Res. 32 (2000) 129
10. Sorenson J.R.J. Prog. Med. Chem. 437 (1989) 26
11. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Cheng N., Chi J., and Feng J. Diabetes 46 (1997) 1786
12. Munoz M.C., Barbera A., Dominguez J., Fernandez-Alvarez J., Gomis R., and Guinovart J.J. Diabetes 50 (2001) 131
13. Sakurai H. Chem. Rec. 2 (2002) 237
14. Sakurai H., Yasui H., and Adachi Y. Expert Opin. Invest. Drugs 12 (2003) 1189
15. Sakurai H., and Adachi Y. Biometals 18 (2005) 319
16. Sakurai H., Katoh A., and Yoshikawa Y. Bull. Chem. Soc. Jpn. 11 (2006) 1645
17. Goldwaser I., Gefel D., Gershonov E., Fridkin M., and Shechter Y. J. Inorg. Biochem. 80 (2000) 21
18. Srivastava A.K., and Mehdi M.Z. Diabetes Med. 22 (2005) 2
19. Thompson K.H., and Orvig C. J. Inorg. Biochem. 100 (2006) 1925
20. Sakurai H., Tsuchiya K., Nukatsuka M., Kawada J., Ishikawa S., Yoshida H., and Komatsu M. J. Clin. Biochem. Nutr. 8 (1990) 193
21. Sakurai H., Fujii K., Watanabe H., and Tamura H. Biochem. Biophys. Res. Commun. 214 (1995) 10950
22. Krieger I., Cash R., and Evans G.W. J. Pediatr. Gastroenterol. Nutr. 3 (1984) 62
23. Barrie S.A., Wright J.V., Pizzorno J.E., Kutter E., and Barron P.C. Agents and Actions 21 (1987) 223
24. Aggett P.J., Fenwick P.K., and Kirk H. J. Nutr. 119 (1989) 1432
25. Ray M.M. Austr. J. Chem. 19 (1966) 1737
26. Bannister W.H., Bannister J.V., Searle A.J.F., and Thornalley P.J. Inorg. Chim. Acta 78 (1983) 139
27. Diane M.S., and William H.A. Inorg. Chem. 31 (1992) 5178
28. Barandika M.G., Serna Z.E., Urtiaga M.K., Larramendi J.I.R., Arriortua M.I., and Cortes R. Polyhedron 18 (1999) 1311
29. Yoshikawa Y., Ueda E., Kawabe K., Miyake H., Takino T., Sakurai H., and Kojima Y. J. Biol. Inorg. Chem. 7 (2002) 68
30. March R., Clegg W., Coxall R.A., Cucurull S.L., Lezama L., Rojo T., and Gonzalez D.P. Inorg. Chim. Acta 353 (2003) 129
31. Nakai M., Watanabe H., Fujisawa C., Kakegawa H., Satoh T., Takada J., Matsushita R., and Sakurai H. Biol. Pharm. Bull. 18 (1995) 719
32. Sakurai H., Nishida M., Yoshimura T., Takada J., and Koyama M. Biochim. Biophys. Acta 841 (1985) 208
33. Liccione J., and Maines M. J. Pharmacol. Exp. Ther. 247 (1988) 156
34. Chen J.Y., Tsao G.C., Zhao Q., and Zheng W. Toxicol. Appl. Pharmacol. 175 (2001) 160
35. Jones M.M., Schoenheit J.E., and Weaver A.D. Toxicol. Appl. Pharmacol. 49 (1979) 41
36. Thompson K.H., Chiles J., Yuen V.G., Tse J., McNeill J.H., and Orvig C. J. Inorg. Biochem. 98 (2004) 683
37. Abdul-Ghani A.S., Abu-Hijeh A.L., Nahas N., and Amin R. Biol. Trace Elem. Res. 54 (1996) 143
38. Nakai M., Sekiguchi F., Obata M., Ohtsuki C., Adachi Y., Sakurai H., Orvig C., Rehder D., and Yano S. J. Inorg. Biochem. 99 (2005) 1275
39. Kawabe K., Tadokoro M., Ichimura A., Kojima Y., Takino T., and Sakurai H. J. Am. Chem. Soc. 121 (1999) 7937
40. Fugono J., Fujimoto K., Yasui H., Kawabe K., Yoshikawa Y., Kojima Y., and Sakurai H. Drug Metab. Pharmacokin. 17 (2002) 340
41. Sakurai H., Tamura A., Fugono J., Yasui H., and Sakurai H. Coord. Chem. Rev. 245 (2003) 31
42. Winter C.L., Lange J.S., Davis M.S., Gerwe G.S., Downs T.R., Peters K.G., and Kashibhatla B. Exp. Biol. Med. 230 (2005) 207
43. Seale A.P., Jesus L.A., Kim A.Y., Choi Y.H., Lim H.B., Hwang C.S., and Kim Y.S. Biotech. Lett. 27 (2005) 221
44. Basuki W., Hiromura M., Adachi Y., Tayama K., Hattori M., and Sakurai H. Biochem. Biophys. Res. Commun. 349 (2006) 1163
45. Ostrakhovitch E.A., Lordnejad M.R., Schliess F., Sies H., and Klotz L. Arch. Biochem. Biophys. 397 (2002) 232
46. Ostrakhovitch E.A., and Cherian M.G. Arch. Biochem. Biophys. 423 (2004) 351
47. Mosman T. J. Immun. Meth. 65 (1983) 55